2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

  • Introduction Upper GI to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0G3HZ
  • Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0G3KZ
  • Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0G3NZ
  • Introduction Upper GI to Other Gas with Gas, Percutaneous Approach - 3E0G3SF
  • Introduction Upper GI to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0G3TZ
  • Introduction Upper GI to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0G4GC
  • Introduction Upper GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G704
  • Introduction Upper GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G705
  • Introduction Upper GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0G70M
  • Introduction Upper GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0G728
  • Introduction Upper GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0G729
  • Introduction Upper GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0G73Z
  • Introduction Upper GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0G76Z
  • Introduction Upper GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0G77Z
  • Introduction Upper GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0G7BZ
  • Introduction Upper GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0G7GC
  • Introduction Upper GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0G7HZ
  • Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0G7KZ
  • Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0G7NZ
  • Introduction Upper GI to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0G7SF
  • Introduction Upper GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0G7TZ
  • Introduction Upper GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G804
  • Introduction Upper GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G805
  • Introduction Upper GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0G80M
  • Introduction Upper GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0G828
  • Introduction Upper GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0G829
  • Introduction Upper GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0G83Z
  • Introduction Upper GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G86Z
  • Introduction Upper GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G87Z
  • Introduction Upper GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8BZ
  • Introduction Upper GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8GC
  • Introduction Upper GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8HZ
  • Introduction Upper GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8KZ
  • Introduction Upper GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8NZ
  • Introduction Upper GI to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8SF
  • Introduction Upper GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0G8TZ
  • Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0H304
  • Introduction Lower GI to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0H305
  • Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0H30M
  • Introduction Lower GI to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0H328
  • Introduction Lower GI to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0H329
  • Introduction Lower GI to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0H33Z
  • Introduction Lower GI to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0H36Z
  • Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0H37Z
  • Introduction Lower GI to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0H3BZ
  • Introduction Lower GI to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0H3GC
  • Introduction Lower GI to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0H3HZ
  • Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0H3KZ
  • Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0H3NZ
  • Introduction Lower GI to Other Gas with Gas, Percutaneous Approach - 3E0H3SF
  • Introduction Lower GI to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0H3TZ
  • Introduction Lower GI to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0H4GC
  • Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H704
  • Introduction Lower GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H705
  • Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach - 3E0H70M
  • Introduction Lower GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach - 3E0H728
  • Introduction Lower GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach - 3E0H729
  • Introduction Lower GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach - 3E0H73Z
  • Introduction Lower GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach - 3E0H76Z
  • Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach - 3E0H77Z
  • Introduction Lower GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach - 3E0H7BZ
  • Introduction Lower GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach - 3E0H7GC
  • Introduction Lower GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach - 3E0H7HZ
  • Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach - 3E0H7KZ
  • Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach - 3E0H7NZ
  • Introduction Lower GI to Other Gas with Gas, Via Natural or Artificial Opening Approach - 3E0H7SF
  • Introduction Lower GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach - 3E0H7TZ
  • Introduction Lower GI to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H804
  • Introduction Lower GI to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H805
  • Introduction Lower GI to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach - 3E0H80M
  • Introduction Lower GI to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0H828
  • Introduction Lower GI to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach - 3E0H829
  • Introduction Lower GI to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach - 3E0H83Z
  • Introduction Lower GI to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H86Z
  • Introduction Lower GI to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H87Z
  • Introduction Lower GI to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8BZ
  • Introduction Lower GI to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8GC
  • Introduction Lower GI to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8HZ
  • Introduction Lower GI to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8KZ
  • Introduction Lower GI to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8NZ
  • Introduction Lower GI to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8SF
  • Introduction Lower GI to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach - 3E0H8TZ
  • Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach - 3E0J304
  • Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E0J305
  • Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0J30M
  • Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E0J328
  • Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E0J329
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0J33Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0J36Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0J37Z
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E0J3BZ
  • Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E0J3GC
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E0J3HZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E0J3KZ
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E0J3NZ
  • Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Percutaneous Approach - 3E0J3SF
  • Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Percutaneous Approach - 3E0J3TZ
  • Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Percutaneous Approach - 3E0J3U0
  • Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Percutaneous Approach - 3E0J3U1
  • Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach - 3E0J4GC